NCT00002652View on ClinicalTrials.gov

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1995

Study Completion Date

February 29, 2004

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

suramin

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Arkansas

OTHER

NCT00002652 - Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease | Biotech Hunter | Biotech Hunter